Incidence of retinopathy in chronic Hepatitis C patients treated with pegylated interferon alpha 2a and ribavirin combination therapy

被引:0
作者
Kashif, Muhammad [1 ,2 ]
Saleem, Muhammad Khurram [1 ]
Farooka, Imran Khan [2 ]
Husnain, Amino [2 ]
Siddiqui, Arif Mahmood [2 ]
机构
[1] Combined Mil Hosp Lahore, CMH Lahore Med Coll, Lahore, Pakistan
[2] Jinnah Hosp Lahore, Med Unit 2, Lahore, Pakistan
关键词
Chronic Hepatitis C patients; Pegylated interferon alpha 2a and ribavirin combination therapy; Retinopathy; CYSTOID MACULAR EDEMA; COMPLICATIONS;
D O I
10.12669/pjms.311.6321
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: The objective of this study was to determine the incidence of retinopathy in chronic hepatitis C patients treated with Pegylated interferon alpha 2a and Ribavirin. Methods: This descriptive case series study was conducted in Medical Unit II of the Jinnah Hospital Lahore from September 2012 to February 2013. One hundred chronic hepatitis C patients visiting Medical Unit II outpatient department fulfilling inclusion criteria were selected for this study via non probability purposive sampling. Patients were started on pegylated interferon and ribavirin combination therapy. Subjects were subjected to dilated eye fundoscopic examination at the start of therapy and then after three months of the therapy. Results: One hundred patients were included in this study. Out of these 100 patients 5% developed retinopathy whereas fundus examination was normal in rest of the patients. Conclusion: Interferon therapy can lead to retinopathy. Periodic fundoscopic examinations help in early detection and prevent progression to permanent visual loss.
引用
收藏
页码:174 / 177
页数:4
相关论文
共 14 条
[1]  
Ansari N, 2002, J Pak Med Assoc, V52, P219
[2]  
Ávila Marcos Pereira de, 2006, Arq. Bras. Oftalmol., V69, P255
[3]   Is screening for interferon retinopathy in hepatitis C justified? [J].
Cuthbertson, FM ;
Davies, M ;
McKibbin, M .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2004, 88 (12) :1518-1520
[4]   Interferon-induced retinopathy in asymptomatic cancer patients [J].
Esmaeli, B ;
Koller, C ;
Papadopoulos, N ;
Romaguera, J .
OPHTHALMOLOGY, 2001, 108 (05) :858-860
[5]  
Khan Hassan, 2008, J Pak Med Assoc, V58, P48
[6]   Retinopathy in hepatitis C patients due to combination therapy with pegylated interferon and ribavirin [J].
Kim, Ei Tae ;
Kim, Lee Hoo ;
Lee, Jung Il ;
Chin, Hee Seung .
JAPANESE JOURNAL OF OPHTHALMOLOGY, 2009, 53 (06) :598-602
[7]   Pegylated-Interferon-Associated Retinopathy in Chronic Hepatitis Patients [J].
Lim, Ji Won ;
Shin, Min-Cheol .
OPHTHALMOLOGICA, 2010, 224 (04) :224-229
[8]  
Meltzer D., 2008, OPTOMETRY, V79, P320
[9]   Ophthalmologic Complications in Children With Chronic Hepatitis C Treated With Pegylated Interferon [J].
Narkewicz, Michael R. ;
Rosenthal, Philip ;
Schwarz, Kathleen B. ;
Drack, Arlene ;
Margolis, Todd ;
Repka, Michael X. .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2010, 51 (02) :183-186
[10]   Risk factors for retinopathy associated with interferon α-2b and ribavirin combination therapy in patients with chronic hepatitis C [J].
Okuse, Chiaki ;
Yotsuyanagi, Hiroshi ;
Nagase, Yoshihiko ;
Kobayashi, Yuhtaro ;
Yasuda, Kiyomi ;
Koike, Kazuhiko ;
Iino, Shiro ;
Suzuki, Michihiro ;
Itoh, Fumio .
WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (23) :3756-3759